Adaptive Biotechnologies (ADPT) Assets Average (2019 - 2026)

Adaptive Biotechnologies (ADPT) has 8 years of Assets Average data on file, last reported at $509.3 million in Q1 2026.

• Quarterly Assets Average fell 3.0% year-over-year to $509.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $509.3 million (down 3.0% YoY) and the FY2025 annual result came in at $526.1 million, down 12.36% from the prior year.
• Assets Average rose to $509.3 million in Q1 2026 per ADPT's latest filing, from $501.7 million in the prior quarter.
• The five-year high for Assets Average was $890.8 million in Q1 2022, with the low at $493.6 million in Q3 2025.
• Average Assets Average over 5 years is $668.8 million, with a median of $640.7 million recorded in 2024.
• Year-over-year, Assets Average slipped 22.86% in 2024 and fell 3.0% in 2026.
• Adaptive Biotechnologies' Assets Average stood at $870.4 million in 2022, then fell by 20.8% to $689.4 million in 2023, then declined by 20.38% to $548.9 million in 2024, then decreased by 8.61% to $501.7 million in 2025, then rose by 1.53% to $509.3 million in 2026.
• Business Quant data shows ADPT's Assets Average at $509.3 million in Q1 2026, $501.7 million in Q4 2025, and $493.6 million in Q3 2025.